Skip to Content

What is the cost of Kymriah?

Medically reviewed by Last updated on Sep 30, 2019.

Official Answer


According to Novartis, the manufacturer of Kymriah (tisagenlecleucel), the cancer therapy will cost $475,000 for one treatment course.

Kymriah is a chimeric antigen receptor T cell (CAR-T) therapy for use in pediatric and young adult patients (up to age 25) with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL).

Related Medical Questions

Drug Information

Related Support Groups